ETHZilla Corporation (ETHZ)
| Market Cap | 397.91M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -17.22M |
| Shares Out | 164.43M |
| EPS (ttm) | -6.03 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,668,768 |
| Open | 2.480 |
| Previous Close | 2.550 |
| Day's Range | 2.350 - 2.510 |
| 52-Week Range | 0.658 - 17.750 |
| Beta | 0.39 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 26, 2025 |
About ETHZ
ETHZilla Corporation, a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases in the United States. The company product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren’s Contracture; and Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close ... [Read more]
Financial Performance
Financial StatementsNews
ETHZilla Announces Initial ETH Yield Allocation & Additional Stock Repurchases
Company repurchased a total of approximately 6.0 million shares this month at an average price of $2.50 per share Executing on deployment of ETH into L2 protocols PALM BEACH, Fla. , Sept. 15, 2025 /PR...
ETHZilla Announces ETH Accumulation and Leadership Updates
Company has accumulated 102,246 ETH at an average acquisition price of $3,948.72, valued at approximately $443 million McAndrew Rudisill appointed as Chief Executive Officer, will continue to serve as...
ETHZilla Plans to Deploy $100 Million in ETH to EtherFi for Restaking Initiatives
Partnership marks ETHZilla's first engagement with DeFi protocols Company has accumulated 102,246 ETH at an average acquisition price of $3,948.72, valued at approximately $456 million PALM BEACH, Fla...
Bitcoin erases summer gains, crypto treasury stocks fall in August
CNBC's MacKenzie Sigalos joins "Closing Bell" to report on bitcoin giving up its summer gains, ether finishing the month higher, and muted ETF inflows.
New Ether Treasury ETHZilla Stock Jumps on Buyback Program
Shares of ETHZilla (ETHZ) soared 9% Monday as the cryptocurrency treasury firm announced an up to $250 million stock repurchase plan and gave an update on its holding of Ether.
ETHZilla announces authorization of $250 million stock repurchase program
Company has accumulated 102,237 ETH at an average acquisition price of $3,948.72, which is now valued at approximately $489 million Announces implementation of proprietary Electric Asset Protocol to g...
Crypto Treasury stocks see pullback in August
CNBC's Tanaya Macheel joins 'Closing Bell Overtime' to break down why crypto treasuries have seen dramatic pull backs in August.
ETHZilla Unveils New Brand Committed to Advancing Ethereum Treasury Strategy
Company announces new ticker (formally ATNF) and will begin trading on NASDAQ under ETHZ on August 18, 2025 Company has accumulated 94,675 ETH at an average acquisition price of $3,902.20, which is no...
180 Life Sciences (ETHZilla) Holds 82,186 ETH
Company Initiates Institutional ETH Accumulation Strategy PALO ALTO, Calif. , Aug. 12, 2025 /PRNewswire/ -- 180 Life Sciences Corp. (Nasdaq: ATNF), dba ETHZilla (the "Company", "180 Life Sciences" or ...
180 Life Sciences Announces Closing of Private Offering of Approximately $156 Million of Convertible Notes
Company intends to use the net proceeds from this financing primarily to rapidly increase its ETH holdings This milestone follows the announcement of the Company's recently closed $425 million private...
180 Life Sciences Closes $425 Million Private Placement to Advance its Ethereum Treasury Strategy
Company intends to use the net proceeds from this financing primarily to rapidly increase its ETH holdings Company plans to execute a differentiated yield generation program, with Company built for th...
180 Life Sciences Announce an Upsized $425 Million Private Placement to Establish an Ether Treasury Reserve Led by Consortium of Digital Asset Leaders to Launch ETHZilla
180 Life Sciences announces entry into PIPE funding documents to raise $425 million in gross proceeds to launch next generation Ethereum treasury strategy and planned rebranding to ETHZilla PALO ALTO,...
180 Life Sciences Corp. Announces Strengthening of Legacy Intellectual Property Assets
PALO ALTO, CA / ACCESS Newswire / July 1, 2025 / 180 Life Sciences Corp. (NASDAQ:ATNF) ("180" or the "Company), an innovative biotechnology company that is currently pivoting to the global iGaming sec...
180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction
PALO ALTO, CA / ACCESS Newswire / May 1, 2025 / 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), an innovative media and entertainment company focused on the global iGamin...
180 Life Sciences Corp. Announces Share Repurchase
PALO ALTO, CALIFORNIA / ACCESS Newswire / April 30, 2025 / 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences," the "Company," "we," or "us") today announced that it has entered into a Settleme...
180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules
PALO ALTO, CA / ACCESSWIRE / December 27, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF), a biotechnology company that is currently refocusing its business on the international ...
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules
PALO ALTO, CA / ACCESSWIRE / December 12, 2024 / 180 Life Sciences Corp. ("180" or the "Company") is pleased to announce that it has regained compliance with Nasdaq Listing Rule 5605(c)(2), which requ...
180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors
PALO ALTO, CA / ACCESSWIRE / December 4, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF), a biotechnology company that is currently refocusing its business on the international e...
180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration
PALO ALTO, CA / ACCESSWIRE / October 31, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today announced the retention of Mr. Vaclav Vincalek as Senior Technology Consultant.
180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors
PALO ALTO, CA / ACCESSWIRE / October 29, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today announced the appointment of Mr. Jay Goodman to its Board of Directors, effective i...
This biotech stock soared a whopping 900% on Wednesday: here's why
180 Life Sciences Corp (NASDAQ: ATNF), a biotech firm, saw its shares skyrocket by 900% on Wednesday following the acquisition of a blockchain-enabled platform. This strategic move marks a significant...
180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Letter to Stockholders; Provides Update on Newly Acquired Gaming Technology Platform
PALO ALTO, CA / ACCESSWIRE / October 16, 2024 / 180 Life Sciences Corp. (NASDAQ:ATNF)("180" or the "Company"), today released the following letter to stockholders from its Interim Chief Executive Offi...
180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector
PALO ALTO, CA / ACCESSWIRE / October 9, 2024 / 180 Life Sciences Corp. (NASDAQ:ATNF) (the "Company" or "180"), is pleased to announce that it has received confirmation from Nasdaq that the Company has...
180 Life Sciences Corp. - Corporate Updates
Announcing Acquisition of Advanced Gaming Technology Platform, Positive Progress on Legacy CBD Formulation, and Strengthened Balance Sheet PALO ALTO, CA / ACCESSWIRE / October 3, 2024 / 180 Life Scien...